Description of Event or Problem · 1
THIS PRODUCT MEETS THE CRITERIA FOR A 5-DAY MDR AS DESCRIBED IN THE FDA'S NOTICE DATED APRIL 8, 2008 [TO MFRS AND INITIAL DISTRIBUTORS OF MEDICAL DEVICES THAT MAY CONTAIN HEPARIN OR ARE HEPARIN-COATED], AND ABBOTT IS SUBMITTING THIS 5-DAY MDR. OUR INVESTIGATION INTO THIS EVENT IS ONGOING AND A SUPPLEMENTAL MDR WILL BE SUBMITTED AT THE CONCLUSION OF OUR INVESTIGATION. ON 4/21/2008, ABBOTT POINT OF CARE WAS CONTACTED BY A CUSTOMER WHO REPORTED AN I-STAT CARDIAC TROPONIN I CARTRIDGE YIELDED A WHOLE BLOOD RESULT OF 0.67 NG/ML. THE SAME WHOLE BLOOD SAMPLE REPEATED ON AN I-STAT CARDIAC TROPONIN I CARTRIDGE YIELDED A RESULT OF 1.3 NG/ML. A SAMPLE (UNK IF SAME OR DIFFERENT SAMPLE) TESTED USING A LABORATORY SYSTEM YIELDED A RESULT OF 0.01 NG/ML. NO OTHER DIAGNOSTIC INFO PROVIDED.